Funding for this research was provided by:
Hormozgan University of Medical Sciences (990592)
Received: 24 February 2021
Accepted: 27 February 2021
First Online: 8 March 2021
: The present trial was approved by the Ethics Committee of Hormozgan University of Medical Sciences (Ethics committee reference number: IR.HUMS.REC.1399.526) on November 14, 2021. The investigators declare the trial has received ethical approval from the appropriate ethical committee, as described above. A signed informed consent freely complete by all participants before randomization.
: Not applicable.
: The authors declare that they have no competing interests.